MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis Q Su, V Kumar, N Sud, RI Mahato Advanced drug delivery reviews 129, 54-63, 2018 | 118 | 2018 |
Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205 AK Chaudhary, G Mondal, V Kumar, K Kattel, RI Mahato Cancer letters 402, 1-8, 2017 | 106 | 2017 |
miRNA profiling in pancreatic cancer and restoration of chemosensitivity S Singh, D Chitkara, V Kumar, SW Behrman, RI Mahato Cancer letters 334 (2), 211-220, 2013 | 91 | 2013 |
Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer V Kumar, G Mondal, P Slavik, S Rachagani, SK Batra, RI Mahato Molecular pharmaceutics 12 (4), 1289-1298, 2015 | 88 | 2015 |
Challenges and recent advances in medulloblastoma therapy V Kumar, V Kumar, T McGuire, DW Coulter, JG Sharp, RI Mahato Trends in pharmacological sciences 38 (12), 1061-1084, 2017 | 79 | 2017 |
Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis V Kumar, X Xin, J Ma, C Tan, N Osna, RI Mahato Advanced drug delivery reviews 176, 113888, 2021 | 75 | 2021 |
Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis V Kumar, G Mondal, R Dutta, RI Mahato Biomaterials 76, 144-156, 2016 | 70 | 2016 |
Micellar delivery of cyclopamine and gefitinib for treating pancreatic cancer D Chitkara, S Singh, V Kumar, M Danquah, SW Behrman, N Kumar, ... Molecular pharmaceutics 9 (8), 2350-2357, 2012 | 59 | 2012 |
EGFR-targeted polymeric mixed micelles carrying gemcitabine for treating pancreatic cancer G Mondal, V Kumar, SK Shukla, PK Singh, RI Mahato Biomacromolecules 17 (1), 301-313, 2016 | 54 | 2016 |
Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy X Xin, V Kumar, F Lin, V Kumar, R Bhattarai, VR Bhatt, C Tan, RI Mahato Science advances 6 (46), eabd6764, 2020 | 51 | 2020 |
Delivery and targeting of miRNAs for treating liver fibrosis V Kumar, RI Mahato Pharmaceutical research 32, 341-361, 2015 | 51 | 2015 |
Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis V Kumar, V Mundra, RI Mahato Pharmaceutical research 31, 1158-1169, 2014 | 51 | 2014 |
Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice V Kumar, V Mundra, Y Peng, Y Wang, C Tan, RI Mahato Theranostics 8 (15), 4033, 2018 | 45 | 2018 |
Design of Hedgehog pathway inhibitors for cancer treatment J Bariwal, V Kumar, Y Dong, RI Mahato Medicinal research reviews 39 (3), 1137-1204, 2019 | 38 | 2019 |
Design, synthesis and biological evaluation of novel hedgehog inhibitors for treating pancreatic cancer V Kumar, AK Chaudhary, Y Dong, HA Zhong, G Mondal, F Lin, V Kumar, ... Scientific reports 7 (1), 1665, 2017 | 36 | 2017 |
Impact of miRNA-mRNA profiling and their correlation on medulloblastoma tumorigenesis RIM Vinod Kumar, Virender Kumar, Amit Kumar Chaudhary, Donald W. Coulter ... Molecular Therapy: Nucleic Acid, 2018 | 35 | 2018 |
ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating Medulloblastoma in mice Q Wang, V Kumar, F Lin, B Sethi, DW Coulter, TR McGuire, RI Mahato Journal of controlled release 323, 463-474, 2020 | 33 | 2020 |
Organic nanocarriers for delivery and targeting of therapeutic agents for cancer treatment Y Peng, J Bariwal, V Kumar, C Tan, RI Mahato Advanced Therapeutics 3 (2), 1900136, 2020 | 29 | 2020 |
Biodistribution of self-assembling polymer–gemcitabine conjugate after systemic administration into orthotopic pancreatic tumor bearing mice K Kattel, G Mondal, F Lin, V Kumar, RI Mahato Molecular pharmaceutics 14 (5), 1365-1372, 2017 | 29 | 2017 |
Therapeutic Potential of OMe-PS-miR-29b1 for treating Liver Fibrosis RIM Virender Kumar, Vinod Kumar, Jiangtao Luo Molecular Therapy, 2018 | 24 | 2018 |